Cart
×
Dyne Therapeutics will present initial clinical data, first released on January 3rd, 2024, from the DELIVER trial of DYNE-251 in patients with Duchenne muscular dystrophy (DMD) who are amenable to exon 51 skipping
DATE: Tuesday, February 13, 2024
TIME: 11:00AM – 12:00PM PST
SPEAKERS: Ash Dugar, PhD, MBA- Chief Medical Affairs Officer